Prediction of molecular interaction between platelet glycoprotein Ibα and von Willebrand factor using molecular dynamics simulations

Journal of Atherosclerosis and Thrombosis

Volumn 23, Issue 4, 2016, Pages 455-464

  Shiozaki, Seiji ^a   Takagi, Shu ^b   Goto, Shinya ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Flow; Glycoprotein Ib; Platelet shear; Von Willebrand factor

Indexed keywords

GLYCOPROTEIN IB; GLYCOPROTEIN IB ALPHA; VON WILLEBRAND FACTOR; PROTEIN BINDING; THROMBIN RECEPTOR;

ARTICLE; BIOMECHANICS; FORCE; GENE MUTATION; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; SHEAR STRESS; THROMBOCYTE ADHESION; BINDING SITE; CHEMISTRY; CONFORMATION; HUMAN; MECHANICAL STRESS; PROTEIN DOMAIN; SHEAR STRENGTH; THROMBOCYTE;

BINDING SITES; BLOOD PLATELETS; HUMANS; MOLECULAR CONFORMATION; MOLECULAR DYNAMICS SIMULATION; PLATELET ADHESIVENESS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROTEIN BINDING; PROTEIN DOMAINS; SHEAR STRENGTH; STRESS, MECHANICAL; VON WILLEBRAND FACTOR;

EID: 84962382992     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.32458     Document Type: Article

References (57)

1. Kawamura Y, Takahari Y, Tamura N, Eguchi Y, Urano T, Ishida H and Goto S. Imaging of structural changes in endothelial cells and thrombus formation at the site of FeCl(3)-induced injuries in mice cremasteric arteries. J Atheroscler Thromb. 2009; 16: 807-814
2. Andre P, Denis CV, Ware J, Saffaripour S, Hynes RO, Ruggeri ZM and Wagner DD. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood. 2000; 96: 3322-3328
3. McGhie AI, McNatt J, Ezov N, Cui K, Mower LK, Hagay Y, Buja LM, Garfinkel LI, Gorecki M and Willerson JT. Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain. Circulation. 1994; 90: 2976-2981
4. Savage B, Saldivar E and Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996; 84: 289-297
5. Goto S, Ikeda Y, Saldivar E and Ruggeri ZM. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest. 1998; 101: 479-486
6. Shattil SJ, Motulsky HJ, Insel PA, Flaherty L and Brass LF. Expression of fibrinogen receptors during activation and subsequent desensitization of human platelets by epinephrine. Blood. 1986; 68: 1224-1231
7. Niiya K, Hodson E, Bader R, Byers-Ward V, Koziol JA, Plow EF and Ruggeri ZM. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation. Blood. 1987; 70: 475-483
8. Michelson AD and Barnard MR. Thrombin-induced changes in platelet membrane glycoproteins Ib, IX, and IIb-IIIa complex. Blood. 1987; 70: 1673-1678
9. Goto S, Salomon DR, Ikeda Y and Ruggeri ZM. Characterization of the unique mechanism mediating the sheardependent binding of soluble von Willebrand factor to platelets. J Biol Chem. 1995; 270: 23352-23361
10. Shiozaki S, Ishikawa, KL, Takagi, S. Numerical study on platelet adhesion to vessel walls using the kinetic monte carlo method. J Biomech Sci Eng. 2011; 7: 275-293
11. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL and Deykin D. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982; 307: 1432-1435
12. Banno F, Kaminaka K, Soejima K, Kokame K and Miyata T. Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease. J Biol Chem. 2004; 279: 30896-30903
13. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M and Lammle B. von Willebrand factorcleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med. 1998; 339: 1578-1584
14. Kim J, Zhang CZ, Zhang X and Springer TA. A mechanically stabilized receptor-ligand flex-bond important in the vasculature. Nature. 2010; 466: 992-995
15. Tobimatsu H, Nishibuchi Y, Sudo R, Goto S and Tanishita K. Adhesive Forces between A1 Domain of von Willebrand Factor and N-terminus Domain of Glycoprotein Ibalpha Measured by Atomic Force Microscopy. J Atheroscler Thromb. 2015; 22: 1091-1099
16. Liu G, Fang Y and Wu J. A mechanism for localized dynamics-driven affinity regulation of the binding of von Willebrand factor to platelet glycoprotein Ibalpha. J Biol Chem. 2013; 288: 26658-26667
17. Li J, Zhang L and Sun Y. Molecular basis of the initial platelet adhesion in arterial thrombosis: molecular dynamics simulations. Journal of molecular graphics & modelling. 2012; 37: 49-58
18. Doucet J and Benoit JP. Molecular dynamics studied by analysis of the X-ray diffuse scattering from lysozyme crystals. Nature. 1987; 325: 643-646
19. Dumas JJ, Kumar R, McDonagh T, Sullivan F, Stahl ML, Somers WS and Mosyak L. Crystal structure of the wildtype von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations. J Biol Chem. 2004; 279: 23327-23334
20. Huizinga EG, Tsuji S, Romijn RA, Schiphorst ME, de Groot PG, Sixma JJ and Gros P. Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science. 2002; 297: 1176-1179
21. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kale L and Schulten K. Scalable molecular dynamics with NAMD. J Comput Chem. 2005; 26: 1781-1802
22. MacKerell AD. Jr., Banavali N and Foloppe N. Development and current status of the CHARMM force field for nucleic acids. Biopolymers. 2000; 56: 257-265
23. Humphrey W, Dalke A and Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996; 14: 33-38, 27-28
24. Abraham MJ and Gready JE. Optimization of parameters for molecular dynamics simulation using smooth particlemesh Ewald in GROMACS 4.5. J Compt Chem. 2011; 32: 2031-2040
25. Grest GS and Kremer K. Molecular dynamics simulation for polymers in the presence of a heat bath. Phys Rev A. 1986; 33: 3628-3631
26. Rajamani R, Naidoo KJ and Gao J. Implementation of an adaptive umbrella sampling method for the calculation of multidimensional potential of mean force of chemical reactions in solution. J Compt Chem. 2003; 24: 1775-1781
27. Kumar S, Rosenberg JM, Bouzida D, Swendsen RH and Kollman PA. Multidimensional Free-Energy Calculations Using the Weighted Histogram Analysis Method. J Compt Chem. 1995; 16: 1339-1350
28. Lera G and Pinzolas M. Neighborhood based Levenberg-Marquardt algorithm for neural network training. IEEE transactions on neural networks/a publication of the IEEE Neural Networks Council. 2002; 13: 1200-1203
29. Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R, Lindhout T, Heemskerk JW, Zirngibl H and Fassler R. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J. 2001; 20: 2120-2130
30. Ruggeri ZM, Orje JN, Habermann R, Federici AB and Reininger AJ. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood. 2006; 108: 1903-1910
31. Celikel R, Varughese KI, Anu Madhusudan, Yoshioka A, Ware J and Ruggeri ZM. Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab. Nat Struct Biol. 1998; 5: 189-194
32. De Marco L, Mazzuccato M, Grazia Del Ben M, Budde U, Federici AB, Girolami A and Ruggeri ZM. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors. J Clin Invest. 1987; 80: 475-482
33. Miyata S and Ruggeri ZM. Distinct structural attributes regulating von Willebrand factor A1 domain interaction with platelet glycoprotein Ibalpha under flow. J Biol Chem. 1999; 274: 6586-6593
34. Murata M, Russell SR, Ruggeri ZM and Ware J. Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment. J Clin Invest. 1993; 91: 2133-2137
35. Murata M, Ware J and Ruggeri ZM. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding. J Biol Chem. 1991; 266: 15474-15480
36. Sugimoto M, Mohri H, McClintock RA and Ruggeri ZM. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib. J Biol Chem. 1991; 266: 18172-18178
37. Weiss HJ, Hoffmann T, Yoshioka A and Ruggeri ZM. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium. J Lab Clin Med. 1993; 122: 324-332
38. Goto S, Ikeda Y, Murata M, Handa M, Takahashi E, Yoshioka A, Fujimura Y, Fukuyama M, Handa S and Ogawa S. Epinephrine augments von Willebrand factordependent shear-induced platelet aggregation. Circulation. 1992; 86: 1859-1863
39. Azuma H, Sugimoto M, Ruggeri ZM and Ware J. A role for von Willebrand factor proline residues 702-704 in ristocetin-mediated binding to platelet glycoprotein Ib. Thromb Haemost. 1993; 69: 192-196
40. Girma JP, Takahashi Y, Yoshioka A, Diaz J and Meyer D. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib. Thromb Haemost. 1990; 64: 326-332
41. Mody NA and King MR. Platelet adhesive dynamics. Part I: characterization of platelet hydrodynamic collisions and wall effects. Biophys J. 2008; 95: 2539-2555
42. Mody NA and King MR. Platelet adhesive dynamics. Part II: high shear-induced transient aggregation via GPIbalpha-vWF-GPIbalpha bridging. Biophys J. 2008; 95: 2556-2574
43. Fogelson AL and Guy RD. Platelet-wall interactions in continuum models of platelet thrombosis: formulation and numerical solution. Math Med Biol. 2004; 21: 293-334
44. Fogelson AL, Hussain YH and Leiderman K. Blood clot formation under flow: the importance of factor XI depends strongly on platelet count. Biophys J. 2012; 102: 10-18
45. Miyazaki H and Yamaguchi T. Formation and destruction of primary thrombi under the influence of blood flow and von Willebrand factor analyzed by a discrete element method. Biorheology. 2003; 40: 265-272
46. Tomita A, Tamura, N., Nanazawa, Y, Shiozaki, S. and Goto, S. Development of Virtual Platelet Implementing the Function of Three Platelet Membrane Proteins with Different Adhesive Characteristics. J Atheroscler Thromb. 2015; 22: 201-210
47. Fogelson AL and Guy RD. Immersed-boundary-type models of intravascular platelet aggregation. Comput Method Appl M. 2008; 197: 2087-2104
48. Northrup SH, Pear MR, McCammon JA and Karplus M. Molecular dynamics of ferrocytochromec. Nature. 1980; 286: 304-305
49. Levitt M. Molecular dynamics of hydrogen bonds in bovine pancreatic trypsin inhibitor protein. Nature. 1981; 294: 379-380
50. Oelschlaeger P, Klahn M, Beard WA, Wilson SH and Warshel A. Magnesium-cationic dummy atom molecules enhance representation of DNA polymerase beta in molecular dynamics simulations: improved accuracy in studies of structural features and mutational effects. J Mol Biol. 2007; 366: 687-701
51. Warshel A. Molecular dynamics simulations of biological reactions. Acc Chem Res. 2002; 35: 385-395
52. Jiang W, Hardy DJ, Phillips JC, Mackerell AD. Jr., Schulten K and Roux B. High-performance scalable molecular dynamics simulations of a polarizable force field based on classical Drude oscillators in NAMD. J Phys Chem Lett. 2011; 2: 87-92
53. Hynninen AP and Crowley MF. New faster CHARMM molecular dynamics engine. J Comput Chem. 2014; 35: 406-413
54. Riahi S and Rowley CN. The CHARMM-TURBOMOLE interface for efficient and accurate QM/MM molecular dynamics, free energies, and excited state properties. J Comput Chem. 2014; 35: 2076-2086
55. Sarzynska J, Reblova K, Sponer J and Kulinski T. Conformational transitions of flanking purines in HIV-1 RNA dimerization initiation site kissing complexes studied by CHARMM explicit solvent molecular dynamics. Biopolymers. 2008; 89: 732-746
56. Sjoqvist J, Linares M, Lindgren M and Norman P. Molecular dynamics effects on luminescence properties of oligothiophene derivatives: a molecular mechanics-response theory study based on the CHARMM force field and density functional theory. Phys Chem Chem Phys. 2011; 13: 17532-17542
57. Shiozaki SI, K. Takagi, S. Numerical study on platelet adhesion to vessel walls using kinetic Monte Carlo Method. J Biomech Eng. 2012; 7: 275-283